Intelligent Bio Solutions (INBS) Shareholder's Equity Growth (1y) (2020 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Intelligent Bio Solutions | 13.61 Mn | 12.40 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | -63.39% |
| Mar 31, 2025 | -55.05% |
| Dec 31, 2024 | 33.26% |
| Sep 30, 2024 | 381.11% |
| Jun 30, 2024 | 121.95% |
| Mar 31, 2024 | 85.56% |
| Dec 31, 2023 | -69.27% |
| Sep 30, 2023 | -76.20% |
| Jun 30, 2023 | -43.67% |
| Mar 31, 2023 | -31.90% |
| Dec 31, 2022 | 2.17% |
| Sep 30, 2022 | -61.51% |
| Jun 30, 2022 | -56.38% |
| Mar 31, 2022 | -45.18% |
| Dec 31, 2021 | -46.52% |
| Sep 30, 2021 | 543.02% |
| Jun 30, 2021 | 387.77% |
| Mar 31, 2021 | 369.79% |
| Dec 31, 2020 | 419.74% |